PhatPharm: Fat Is the New Rx: An Investigative Clinical Memoir and Blueprint for Metabolic Reversal

— —

Pa-C Angela R Akinpelu A O David Akinpelu

PhatPharm

Name: PhatPharm
Price: 63.65 AUD
Availability: OutOfStock
ISBN: 9798989618446

Fat Is the New Rx: An Investigative Clinical Memoir and Blueprint for Metabolic Reversal

Pa-C Angela R Akinpelu, A O David Akinpelu

$74.95 $63.65

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We will update you on expected arrival time to us. If this delay is too long, please let us know within 2 business days and we can give you options regarding cancelling or adjusting your order. More details on cancelling your order can be found in our Terms of Trade.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Rejuve Medical Group
24 April 2026

Dietetics & nutrition; Diabetes; Coping with illness; Diets & dieting

PhatPharm: Fat Is the New Rx tells the story of metabolic disease from both ends of the healthcare continuum. Written by Angela Akinpelu, PA-C, and anchored by a foreword from her husband and RejuVe Medical Group co-founder, David Akinpelu, MD, FACP, the book weaves two clinical perspectives into a single urgent argument: the diseases filling emergency rooms across America are preventable, and dietary fat is the prescription most clinicians have been afraid to write.

Dr. Akinpelu's ER vantage point frames the stakes. He has witnessed the downstream consequences of metabolic dysfunction arriving in acute crisis: strokes, heart failure, diabetic emergencies. Angela's outpatient clinic is where those crises are interrupted upstream. Together, their perspectives form a dual narrative that moves between consequence and reversal, between the cost of ignoring metabolic disease and the clinical reality of reversing it.

At the heart of the book is the PhatPharm Metabolic Reversal Program - a structured, evidence-informed framework for addressing insulin resistance, metabolic syndrome, and chronic inflammatory conditions through therapeutic nutrition, and the foundation of a broader clinical platform at phatpharm.ai. The program is built on the principle of metabolic individuality: the recognition that no single protocol fits every patient, and that lasting reversal depends on understanding how each person's biology responds to fuel. Topics span macronutrient physiology, lipid metabolism, hormonal regulation, hunger and satiety signaling, and the mechanics of fat adaptation, presented with enough rigor for clinicians and enough clarity for patients.

The book dismantles decades of low-fat mythology and makes a direct case for food as pharmacological intervention. With a faith-informed perspective on healing and stewardship, it balances scientific authority with a voice that is personal, direct, and unafraid to challenge the standard of care.

Designed for patients navigating chronic metabolic disease, clinicians seeking a translatable resource, and health-conscious readers ready to move beyond surface-level nutrition advice, PhatPharm: Fat is the New Rx is a comprehensive companion for the metabolic medicine movement at phatpharm.ai.

By: Pa-C Angela R Akinpelu
Foreword by: A O David Akinpelu
Imprint: Rejuve Medical Group
Dimensions: Height: 229mm, Width: 152mm, Spine: 30mm
Weight: 844g
ISBN: 9798989618446
Pages: 382
Publication Date: 24 April 2026
Audience: General/trade , ELT Advanced
Format: Hardback
Publisher's Status: Active

Angela R. Akinpelu, PA-C is the Director of Clinical Operations at RejuVe Medical Group, where she practices collaboratively with her husband, Dr. A.O. David Akinpelu, MD, FACP. Their practice serves patients across two locations - Accokeek, Maryland, and King George, Virginia - with a clinical focus on metabolic reversal, root-cause medicine, and the restoration of cellular energy function in patients who have been managed, rather than healed, by the conventional model.She is the founder of PhatPharm, a metabolic reversal platform comprising a published book, an AI-powered mobile application, and a clinical phenotyping tool used in her practice. Her clinical framework identifies distinct metabolic phenotypes and matches each to targeted ketogenic, fasting, and hybrid pharmaceutical interventions - an approach designed to move patients from lifelong management toward sustained reversal of conditions long treated as chronic and progressive.Beyond clinical practice, Angela co-owns Little Ferry Inn, a hospitality property on the Potomac River in King George, Virginia, and leads several adjacent ventures including Keto Delish Club and Eden's Crown. She writes from the conviction that metabolic disease is reversible, that patient outcomes depend as much on infrastructure as on prescriptions, and that the body, when properly fueled, wants to heal. A.O. David Akinpelu, MD, FACP, is a board-certified physician, Fellow of the American College of Physicians, and experienced emergency department clinician. In PhatPharm, Dr. Akinpelu brings the urgent, high-stakes perspective of the ED - where the consequences of unmanaged metabolic disease arrive in crisis - to complement the outpatient clinical narrative. His frontline experience underscores the critical need for earlier intervention and innovative approaches to metabolic health and type 2 diabetes reversal.